Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults
Citation: Macartney K., Heywood A., McIntyre P. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Database of Systematic Reviews 2014, Issue 6. Art. No.: CD001833. DOI: 10.1002/14651858.CD001833.pub3.
Studies support giving varicella vaccine to a child, particularly if given within three days of contact with a chickenpox case. Although mild chickenpox may still occur in some cases, the vaccine is likely to prevent moderate to severe cases of chickenpox
Many countries do not routinely immunise children against varicella and exposures continue to occur. Although the disease is often mild, complications such as secondary bacterial infection, pneumonitis and encephalitis occur in about 1% of cases, usually leading to hospitalisation. This review found that three separate trials investigated the effectiveness of giving varicella vaccine as post‐exposure prophylaxis following household exposure of non‐immune children to siblings with varicella compared to a placebo. Overall, 13 of 56 (18%) vaccine recipients developed varicella compared with 42 of 54 (78%) placebo (or no vaccine) recipients. The number of participants in these three trials was small and the quality of the included studies varied. There have been no trials of this type undertaken in adults, and none of the trials commented on adverse events following immunisation, such as fever or injection site reactions.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the health of refugees and asylum seekers but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the health of refugees and asylum seekers on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.